Drug Regulator Cracks Down on Unauthorized Weight Loss Drug Sales, Inspects 49 Entities

• National drug regulator intensifies vigil on GLP-1-based weight loss medications due to unauthorized sales and misuse.
• Coordinated inspections conducted at 49 sites, including online pharmacies, wholesalers, and wellness clinics nationwide.
• CDSCO issued a strict advisory warning pharmaceutical companies against promoting prescription weight drugs to the general public.
• DCGI launched a nationwide crackdown on unapproved Fixed Dose Combination (FDCs), examining 90 FDCs.
• Experts warn against reckless consumption of GLP-1 drugs, emphasizing doctor supervision due to potential side effects.